| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Aspire Biopharma Holdings
13G/A
ASBP · 738920107
|
0% |
5/13/2026
Event 12/31/2025
|
||||
| Ardsley Advisory Partners LP | 0% | |||||
| Ardsley Advisory Partners GP LLC | 0% | |||||
| Ardsley Partners I GP LLC | 0% | |||||
| Ardsley Partners Advanced Healthcare Fund, L.P. | 0% | |||||
| Ardsley Partners Fund II, L.P. | 0% | |||||
| Philip J. Hempleman | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.